Characterization of Hydroxypropyl-Beta-Cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1

PLoS ONE - United States
doi 10.1371/journal.pone.0175478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Correction: Characterization of Hydroxypropyl-Beta-Cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1

PLoS ONE
Multidisciplinary
2018English

Niemann-Pick Disease, Type C1 (NPC1)

Science-Business eXchange
2008English

The Prognostic Value of Niemann-Pick C1-Like Protein 1 and Niemann-Pick Disease Type C2 in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

Orphan Designation: Hydroxy-Propyl-Beta-Cyclodextrin, Treatment of Niemann-Pick Disease, Type C

Case Medical Research
2019English

Cessation of Rapid Late Endosomal Tubulovesicular Trafficking in Niemann-Pick Type C1 Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

The Role of the Niemann-Pick Disease, Type C1 Protein in Adipocyte Insulin Action

PLoS ONE
Multidisciplinary
2014English

Niemann-Pick Disease

Turkish Journal of Haematology
Hematology
2011English

Subclinical Course of Adult Visceral Niemann–Pick Type C1 Disease. A Rare or Underdiagnosed Disorder?

Journal of Inherited Metabolic Disease
Genetics
2006English

Endogenous and Synthetic Neurosteroids in Treatment of Niemann–Pick Type C Disease

Brain Research Reviews
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy